CN101229287A - Polynary lycopene preventing and treating eye disease capsule and preparing method thereof - Google Patents
Polynary lycopene preventing and treating eye disease capsule and preparing method thereof Download PDFInfo
- Publication number
- CN101229287A CN101229287A CNA2007100311975A CN200710031197A CN101229287A CN 101229287 A CN101229287 A CN 101229287A CN A2007100311975 A CNA2007100311975 A CN A2007100311975A CN 200710031197 A CN200710031197 A CN 200710031197A CN 101229287 A CN101229287 A CN 101229287A
- Authority
- CN
- China
- Prior art keywords
- lycopene
- polynary
- medicine
- capsule
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a capsule of multi-lycopene for eye diseases treatment and prevention and a preparation method thereof; the capsule is prepared by blending multi-lycopene material A and medicine material B; the material A comprises lycopene, phytoene, phytofluene, Vitamin E and tomato oil; the material B comprises protogen, xanthin, zeaxanthol, cassia seed, wolfberry fruit, euphrasy, bilberry and grape seed extracts; the capsule which is easily absorbed by human bodies and which is prepared by making use of a main anti-oxidative function and a prevention function of synergistic function of the multi-lycopene and an anti-oxidative function, mainly the prevention function of the material B is characterized by being more easily and effectively absorbed by human bodies, being taken conveniently, having evident treatment effect, preventing the aging, degeneration and pathological changes and reducing the incidence rate of eye diseases.
Description
[technical field]
The present invention relates to the capsule that a kind of human body is taken, especially relate to a kind of health and prevent and treat the capsule of ophthalmic of gaining, belong to health product and pharmaceuticals field.
[background technology]
Eyes are visual organ of human body, people wish to have a dual intensity to see the sparkling eyes of external object clearly, and along with the Social Modernization development, the pressure of study and work is increasing, the burden of eyes is also more and more heavier, and going down of vision is more and more with disease of eye.Prevent the health product and the medicament categories of visual deterioration and control disease of eye various in the market, pluses and minuses are respectively arranged, its major defect is that the effect aspect is remarkable inadequately.Research and produce improve the health product of preventing and treating visual deterioration and disease of eye and the effect of medicine is the direction that people make great efforts always, and being necessary to pass through constantly provides after the scientific research some new better to prevent and treat product with effect, and is healthy with the guarantee people.
[summary of the invention]
The purpose of this invention is to provide a kind of new, product that effect is prevented visual deterioration and control disease of eye significantly, solve like product and have the significant inadequately technical problem of effect.
The principle of technical solution of the present invention is: scientific research shows, going down and the generation of disease of human body and human organ function, be because aging, the death of human body cell and human immune system suffer damage, cell owing to oxidation wear out, dead, so improving the human body cell oxidation resistance and repairing the human immune system is the basic of control various diseases, carrying out Drug therapy more just can have significant effect.The present invention adopts the synergistic main strong anti-oxidation function of multiple lycopene, can repair human immune system's function and prevent and treat function according to this principle, cooperate multiple also have anti-oxidation function, main be that the medicine of preventing and treating the ophthalmic function is made the capsule of being taken and absorbing by human body easily, reach the purpose of preventing and treating ophthalmic.
Technical scheme of the present invention is specifically: the multiple lycopene of will have the strong anti-oxidation function, repairing human immune system's function and therapeutical effect is made into the A material with certain proportion; The multiple medicine that will have the ophthalmic remarkable efficacy is made into the B material with certain proportion, then A material and B material is made into capsule by a certain percentage.
The composition that multiple lycopene A material package contains has: lycopene (Lycopene), phytoene (Phytoene), phytofluene (Phetofluene), vitamin E (Tocopherol) and tomato oil (Tomato oil), above-mentioned three kinds of lycopenes are separate constituents of extraction from Fructus Lycopersici esculenti (Tomato), show through scientific research, above-mentioned three kinds of lycopenes have extremely strong anti-oxidation function, can remove various harmful oxygen radicals, wearing out of reducing human cell, repair the human immune system, has defying age, anti-cancer, multiple efficacies and effect such as anticancer, gain health and prevention, treatment multiple disease of human body and ophthalmic.Above-mentioned three kinds of lycopenes are liposoluble substances, need to cooperate tomato oil or pumpkin seed oil or other edible oil and fat materials, so as to give full play to its synergism and easier be absorption of human body.
Still find no at present above-mentioned three kinds of lycopenes are applied to prevent and treat the example and the product of ophthalmic.Vitamin E (Tocopherol) acts on the most extensive in human body, has good antioxygenic property, promptly reduces cell senescence.The human body E that is deficient in vitamin can cause multiple ophthalmic and diseases such as myopia, cataract.
The composition that medicine B material package contains has: thioctic acid (a-Lipoic acid), phylloxanthin (lutein), zeaxanthin (Zeaxanthin), Semen Cassiae (Semen Torae Cassiae), Fructus Lycii (Wolfberry), Herba Euphrasiae Regelii (Eyebright), Pericarpium Citri tangerinae (Bilberry) and OPC (Grape Seed Extract), these medicines all are classical and facts have proved to preventing and treating ophthalmic better and tangible curative effect is arranged.
Thioctic acid (a-Lipoic acid) is that a kind of can the elimination quickened cell senescence and morbific free radical, in human body, after intestinal absorption, enter cell, have fat-soluble and water miscible characteristic concurrently, therefore can go everywhere without any hindrance here at whole body, arrive any one cell position, provide human body comprehensive usefulness, it is a kind of universal antioxidant, can replace when other antioxidant shortage, can strengthen the effect of vitamin E greatly, thioctic acid is made compound recipe with other antioxidant contents, will improve the effect of these antioxidant contents, effectively strengthen immune system in the human body, avoid the destruction of free radical, ophthalmic diseases and other diseases are had therapeutic efficiency.
Phylloxanthin (Lutein) is a kind of potent antioxidant, is the main pigment that constitutes human eye retina's macular area, and human eyes contain the phylloxanthin of a large amount, this element is that human body can't be made, must replenish by taking in phylloxanthin, if lack this element, eyes will lose one's sight.Studies show that and take in phylloxanthin amount height, help to delay aging, degeneration, the pathological changes of eyes, reduce the incidence rate of ophthalmic, can also protect retina to avoid the injury of light, prevent to lack visual deterioration and the blind disease that causes because of phylloxanthin.
Zeaxanthin (Zeaxanthin) is the main component of macular pigment, and macula lutea is positioned at retinal centre, and the quick-eyed and clear wash rice degree of main department if take place to influence the function that vision is accepted unusually, also may cause losing one's sight at last.Have and studies have shown that zeaxanthin can prevent the generation of macula lutea portion degeneration disease.
Semen Cassiae (Semen Torae Cassiae) is sayed the function that it has " controlling optic atrohic blindness, swelling ophthalmalgia, lacrimation " at Shennong's Herbal, successive dynasties Fang Shuzhong can find Seminis Cassiae Bolus, Semen Cassiae ophthalmology prescription such as loose, and is traditional Chinese medical science liver heat removing and eyesight improving commonly used, the key medicine of diuretic relieving constipation.
Fructus Lycii (Wolfberry) shows that according to record of ancient Compendium of Material Medica and modern study the function of nourishing the liver and kidney, replenishing vital essence to improve eyesight is arranged, and is usually used in asthenia damage of essence, soreness of waist and knee joint, vertigo and tinnitus, blurred vision and symptom such as fails to understand.
Herba Euphrasiae Regelii (Eyebright) also is a kind of antioxidant content, has anti-eye strain and improves the reproduction of vision bright eyes, promotes vision and eye function, helps to eliminate eye pouch and black-eyed function.
Pericarpium Citri tangerinae (bilberry) is a kind of natural plants that is rich in anthocyanidin (Anthocyanosides) (Bilberry), anthocyanidin is a kind of potent antioxidant (oxidation resistance is 50 times of vitamin e), can effectively suppress to destroy the ferment of eye cell, be widely used in the acuity and the nyctalopia that improve vision, the health that is of value to eyes has the function and the effect of the ophthalmic of preventing and treating.
Preparation method of the present invention is lycopene A to be expected that each composition stirs in certain proportion make polynary lycopene A material in agitator; Medicine B is expected that each composition stirs in certain proportion make medicine B material in agitator; With polynary lycopene A material and medicine B material stir-concoction and be prepared into capsule in agitator by a certain percentage, its production technology is identical with the technology, the equipment that prepare medicinal soft capsule then.
The invention has the beneficial effects as follows the gain health, improve the eyes function, the effect of preventing and treating ophthalmic is remarkable, and preparation is simple, taking convenience.
[description of drawings]
Fig. 1 is lycopene A material component ratio figure of the present invention, represents with percentage by weight;
Fig. 2 is medicine B material component ratio figure of the present invention, represents with percentage by weight;
Fig. 3 is the ratio chart of A material of the present invention and the blending of B material, represents with percentage by weight.
[specific embodiment]
Below in conjunction with drawings and Examples the present invention is elaborated.
With lycopene (Lycopene) 50 grams (8.4%); Phytoene (Phytoene) 50 grams (0.8%); Phytofluene (Phytofluene) 50 grams (0.8%); Vitamin E (Tocopherol) 200 gram (3.4%) and tomato oils (Tomato oil) 5200 grams (86.6%) amount to 6000 grams (100%) and stir in agitator, make the A material;
With thioctic acid (a-Lipoic acid) 2000 grams (11.1%); Phylloxanthin (Lutein) 500 grams (2.8%); Zeaxanthin (Zeaxanthin) 300 grams (1.7%); Semen Cassiae (Semen Torae Cassiae) 1000 grams (5.6%); Fructus Lycii (Wolfberry) 1000 grams (5.6%); Herba Euphrasiae Regelii (Eyebright) 3000 grams (16.6%); Pericarpium Citri tangerinae (Bilberry) 7200 grams (40.0%); And OPC (Grape seed Extract) 3000 gram (16.6%) amounts to 18000 grams (100%) and stirs in agitator, makes the B material;
A material 6000 grams (25%) and B material 18000 grams (75%) are amounted to 24000 grams (100%) stir-concoction and be prepared into capsule in agitator, and its production technology is identical with the technology, the equipment that prepare medicinal soft capsule.
Claims (3)
1. polynary lycopene preventing and treating eye disease capsule and preparation method thereof, it is characterized in that: its composition that comprises has lycopene (Lycopene), phytoene (Phytoene), phytofluene (Phytofluene), vitamin E (Tocopherol), tomato oil (Tomato oil), thioctic acid (a-Lipoic acid), phylloxanthin (Lutein), zeaxanthin (Zeaxanthin), Semen Cassiae (Semen Torae Cassiae), Fructus Lycii (Wolfberry), Herba Euphrasiae Regelii (Eyebright), Pericarpium Citri tangerinae (Bilberry) and OPC (Grapeseed Extract).
2. polynary lycopene preventing and treating eye disease capsule according to claim 1 and preparation method thereof is characterized in that: described each composition is divided into polynary lycopene A material and medicine B expects two parts, and polynary lycopene A expects that the percentage by weight of each composition is:
Lycopene (Lycopene) 8.4%;
Phytoene (Phytoene) 0.8%;
Phytofluene (Phytofluene) 0.8%;
Vitamin E (Tocopherol) 3.4%;
Tomato oil (Tomato oil) 86.6%;
Amount to 100%;
Medicine B expects that the percentage by weight of each composition is:
Thioctic acid (a-Lipoic acid) 11.1%;
Phylloxanthin (Lutein) 2.8%;
Zeaxanthin (Zeaxanthin) 1.7%;
Semen Cassiae (Semen Torae Cassiae) 5.6%;
Fructus Lycii (Wolfberry) 5.6%;
Herba Euphrasiae Regelii (Eyebright) 16.6%;
Pericarpium Citri tangerinae (Bilberry) 40.0%;
OPC (Grape seed Extract) 16.6%;
Amount to 100%;
The percentage by weight of polynary lycopene A material and medicine B material is:
Polynary lycopene A material 25%;
Medicine B material 75%;
Amount to 100%.
3. polynary lycopene preventing and treating eye disease capsule according to claim 1 and preparation method thereof is characterized in that: A is expected that each composition stirs make polynary lycopene A material in agitator; B is expected that each composition stirs make medicine B material in agitator; Then polynary lycopene A material and medicine B are expected in agitator stir-concoction and be prepared into capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100311975A CN101229287A (en) | 2007-11-02 | 2007-11-02 | Polynary lycopene preventing and treating eye disease capsule and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100311975A CN101229287A (en) | 2007-11-02 | 2007-11-02 | Polynary lycopene preventing and treating eye disease capsule and preparing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101229287A true CN101229287A (en) | 2008-07-30 |
Family
ID=39896300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100311975A Pending CN101229287A (en) | 2007-11-02 | 2007-11-02 | Polynary lycopene preventing and treating eye disease capsule and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101229287A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101670019B (en) * | 2008-09-11 | 2011-08-17 | 郑侠慧 | Complex preparation having radiation-resisting and eyesight-protecting functions |
| CN102742701A (en) * | 2012-07-17 | 2012-10-24 | 北京绿源求证科技发展有限责任公司 | Edible eye caring tea granule for preventing asthenopia |
| CN103446475A (en) * | 2013-08-08 | 2013-12-18 | 贵州神奇药物研究院 | Eye aging-resisting health product and preparation thereof |
| CN107184744A (en) * | 2017-05-19 | 2017-09-22 | 上海宣泰生物科技有限公司 | Purposes of the composition of lycopene and grape seed extract in pharmacy |
-
2007
- 2007-11-02 CN CNA2007100311975A patent/CN101229287A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101670019B (en) * | 2008-09-11 | 2011-08-17 | 郑侠慧 | Complex preparation having radiation-resisting and eyesight-protecting functions |
| CN102742701A (en) * | 2012-07-17 | 2012-10-24 | 北京绿源求证科技发展有限责任公司 | Edible eye caring tea granule for preventing asthenopia |
| CN103446475A (en) * | 2013-08-08 | 2013-12-18 | 贵州神奇药物研究院 | Eye aging-resisting health product and preparation thereof |
| CN103446475B (en) * | 2013-08-08 | 2015-10-28 | 贵州神奇药物研究院 | A kind of health product of anti-eye aging and preparation thereof |
| CN107184744A (en) * | 2017-05-19 | 2017-09-22 | 上海宣泰生物科技有限公司 | Purposes of the composition of lycopene and grape seed extract in pharmacy |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101505773A (en) | Agent for treating eye diseases | |
| CN103417733B (en) | A kind of pharmaceutical composition of alleviating asthenopia | |
| CN104147081A (en) | Blueberry lutein soft capsule for improving eyesight and manufacturing method thereof | |
| CN102225087A (en) | Xanthophyll compound preparation with powerful eye-protecting effect | |
| CN103566049A (en) | Composition for improving density of macular pigment in eyes and preventing or treating age-related macular degeneration | |
| CN104474018A (en) | Health-care soft capsule for relieving asthenopia | |
| CN105362501A (en) | Radiation-preventing and eyesight-protecting beverage, and preparation method thereof | |
| CN105232907A (en) | Beverage capable of invigorating kidney and strengthening Yang and making method thereof | |
| CN106617055A (en) | Eye-protecting healthcare food for relieving degenerative eye diseases and preparation method thereof | |
| CN101229287A (en) | Polynary lycopene preventing and treating eye disease capsule and preparing method thereof | |
| CN103798808A (en) | Nutrient formula and application thereof to food or medicine for reliving asthenopia | |
| CN101999477A (en) | Eyesight-protecting edible oil | |
| CN105106286A (en) | Health product with effects of protecting eyes and improving eyesight | |
| JP2002017295A (en) | Health auxiliary food product having activity for ameliorating eye disease and activity for keeping function of eye | |
| CN103446475B (en) | A kind of health product of anti-eye aging and preparation thereof | |
| CN105983004A (en) | Composition capable of alleviating asthenopia and preparation method | |
| CN108065360A (en) | A kind of cowberry lutein health food | |
| CN101433636A (en) | Composition with function for alleviating eyestrain and preparation method thereof | |
| CN101040893A (en) | Blueberry capsule for protecting vision and the preparing method | |
| CN101433638A (en) | Composition with function for alleviating eyestrain and preparation method thereof | |
| CN103566067A (en) | Composition for treating eye diseases and its application | |
| Sawant | Unique Australian Native Botanical-Lemon Myrtle as a Natural Source of Ocular Health Super-Nutrient | |
| CN105983006A (en) | Composition for relieving visual fatigue and preparation method of composition | |
| CN109123674A (en) | A kind of black fruit fructus lycii compound alleviation visual fatigue piece and its preparation process | |
| CN104905236A (en) | Formula of food-scale health product with effects of radiation damage prevention and repair and eyesight improving |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20080730 |